Evaluating treatment quality for adults with heart attacks in China
Official title: Clinical Performance and Quality Measures for Adults With Acute ST-Elevation Myocardial Infarction in China
Run by China National Center for Cardiovascular Diseases · NCT04088682 · Data updated 2026-11-12
This study is trying to see how well hospitals in China are treating adults who have heart attacks to help improve their care and outcomes.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 200000 (estimated) |
| Sponsor | China National Center for Cardiovascular Diseases Government |
| Locations | 1 site (Beijing, Beijing Municipality) |
| Status | Recruiting |
| Started | July 15, 2018 |
| Main results expected | December 31, 2035 |
| Study ends | December 31, 2035 |
| Registry record updated | October 9, 2019 |
| Trial ID | NCT04088682 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults diagnosed with STEMI who arrive at the hospital within 48 hours of symptom onset.
✕Probably not a fit
Patients who do not present with STEMI or arrive at the hospital after 48 hours from symptom onset may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study investigates clinical performance and quality measures for adults experiencing acute ST-elevation myocardial infarction (STEMI) in China. It involves the annual recruitment of eligible inpatients to collect medical information and assess the performance of participating hospitals. The study aims to develop quality improvement strategies and tools that focus on enhancing treatment and clinical outcomes for STEMI patients. By comparing reperfusion rates and other performance measures annually, the study seeks to generate new knowledge about STEMI management in China.
Why it matters
Potential benefit: If successful, this study could lead to improved treatment protocols and outcomes for patients suffering from STEMI.
How similar studies have gone: Other studies have shown success in improving clinical outcomes through quality improvement strategies in cardiovascular care, indicating that this approach has potential.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with STEMI who arrive at the hospital within 48 hours from the symptoms onset. Exclusion Criteria: * None
Where it's running
-
Hongjian Wang
Beijing, Beijing Municipality, China Recruiting
Study contacts
- Principal investigator: Zhe Zheng — Chinese Academy of Medical Sciences, Fuwai Hospital
- Study coordinator: Hongjian Wang
- Email: wanghongjianfw@hotmail.com
- Phone: 13910008985
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Smartphone AI help for prehospital ECG readings
This study tests whether using a smartphone AI (GPT-4o) to help prehospital providers read 12-lead ECGs improves accuracy in diagnosing acute coronary syndromes and related conditions.
-
Coronary thrombus modification to reduce microvascular damage during STEMI care
This study tests whether modifying the clot in the heart arteries during primary PCI can lessen microvascular damage and myocardial injury in STEMI patients.
-
Crystalline sirolimus-coated balloon for treating coronary artery disease
This tests whether a crystalline sirolimus-coated balloon is safe and effective for adults having percutaneous coronary intervention for coronary artery blockages or in-stent restenosis.
-
Drug-coated balloon treatment during emergency angioplasty for STEMI
This registry will try using drug-coated balloons instead of stents during emergency PCI for people with ST-elevation heart attacks to see how the procedure and patient outcomes compare.
-
Low-level tragus stimulation to improve heart function after ST-elevation heart attack
This trial will see if low-level tragus stimulation applied near the ear can improve heart pumping and wall motion on echocardiogram in people with ST-elevation heart attacks treated with primary PCI.
-
Measuring heart microvascular function in heart attack patients
This study is testing how well the tiny blood vessels in the heart work in people who have had a heart attack to see how treatment affects their recovery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.